One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure
Emerson C. Perin, MD, PH D, a Kenneth M. Borow, MD, b Timothy D. Henry, MD, c Farrell O. Mendelsohn, MD,d Leslie W. Miller, MD, e Elizabeth Swiggum, MD,f Eric D. Adler, MD, g David H. Chang, MD, h R. David Fish, MD,a Alain Bouchard, MD,d Margaret Jenkins, BSC (HONS), i Alex Yaroshinsky, PHD, j Jack Hayes, MA,k Olga Rutman, P HD, k Christopher W. James, PA, k Eric Rose, MD,l Silviu Itescu, MD,l Barry Greenberg, MD
doi : 10.1016/j.jacc.2022.11.061
Volume 81, Issue 9, 7 March 2023, Pages 849-863
Mesenchymal precursor cells (MPCs) are allogeneic, immunoselected cells with anti-inflammatory properties that could improve outcomes in heart failure with reduced ejection fraction (HFrEF).
Mesenchymal Stromal Cell Therapy for Heart Failure: Never Stop DREAMing∗
Philippe Menasché, MD, PH D
doi : 10.1016/j.jacc.2022.12.019
Volume 81, Issue 9, 7 March 2023, Pages 864-866
Initial Findings From the National Cardiovascular Data Registry of Atrial Fibrillation Ablation Procedures
Jonathan C. Hsu, MD, MAS, a, * Douglas Darden, MD, b, * Chengan Du, P HD, c Joseph E. Marine, MD,d Sheila Nichols, MHA, BSN, RN,e Gregory M. Marcus, MD, MAS, f Andrea Natale, MD,g Peter A. Noseworthy, MD,h Kimberly A. Selzman, MD, MPH,i Paul Varosy, MD,j Frederick Masoudi, MD,j James Freeman, MD,c Jeptha Curtis, MD, c Joseph Akar, MD, c Peter R. Kowey, MD
doi : 10.1016/j.jacc.2022.11.060
Volume 81, Issue 9, 7 March 2023, Pages 867-878
The National Cardiovascular Data Registry (NCDR) AFib Ablation Registry was created to assess real-world prevalence, demographic characteristics, procedural management, and outcomes of patients undergoing atrial fibrillation (AF) ablation procedures.
The NCDR AFib Ablation Registry: Better Late Than Never?∗
Matthew R. Reynolds, MD, MS C, Javaria Ahmad, MD
doi : 10.1016/j.jacc.2022.12.017
Volume 81, Issue 9, 7 March 2023, Pages 879-881
Prevalence and Clinical Implications of Tricuspid Valve Prolapse Based on Magnetic Resonance Diagnostic Criteria
Andrada C. Guta, MD, P HD, Kinan C. El-Tallawi, MD, Duc T. Nguyen, MD, PHD, Fatima Qamar, MD, MPH, Thuy Nguyen, MD, William A. Zoghbi, MD, Gerald Lawrie, MD, Edward A. Graviss, PH D, MPH, Dipan J. Shah, MD
doi : 10.1016/j.jacc.2022.11.052
Volume 81, Issue 9, 7 March 2023, Pages 882-893
Tricuspid valve prolapse (TVP) is an uncertain diagnosis with unknown clinical significance because of a scarcity of published data.
Tricuspid Valve Prolapse: A Forgotten Mechanism of Primary Tricuspid Regurgitation?∗
Yuchi Han, MD, MMS C,a Tiffany Chen, MD, b Karima Addetia, MD
doi : 10.1016/j.jacc.2022.12.008
Volume 81, Issue 9, 7 March 2023, Pages 894-896
Association Between Shock Etiology and 5-Year Outcomes After Venoarterial Extracorporeal Membrane Oxygenation
Pichoy Danial, MD, a Maud-Emmanuel Olivier, MD,a Nicolas Bréchot, MD, PHD, b,c Maharajah Ponnaiah, MD,d Thibaut Schoell, MD, a Cosimo D’Alessandro, MD,a Pierre Demondion, MD, a Marina Clément, MD,a Charles Juvin, MD,a Aude Carillion, MD, PH D, c Adrien Bouglé, MD, PHD, c,d Alain Combes, MD, P HD, b,d Pascal Leprince, MD, PHD, a,c Guillaume Lebreton, MD, P HD
doi : 10.1016/j.jacc.2022.12.018
Volume 81, Issue 9, 7 March 2023, Pages 897-909
Outcomes of patients requiring venoarterial extracorporeal membrane oxygenation (VA-ECMO) vary greatly by etiology, but large studies that incorporate the spectrum of shock supported with ECMO are rare.
VA-ECMO When All Seems Lost: Defining the Right Person, Place, and Time∗
Juan J. Russo, MD, a Lorenzo Del Sorbo, MD
doi : 10.1016/j.jacc.2023.01.010
Volume 81, Issue 9, 7 March 2023, Pages 910-912
Pericoronary Adipose Tissue as a Marker of Cardiovascular Risk: JACCÂ Review Topic of the Week
Neville Tan, MBBS, MPH, a,b Damini Dey, PH D, c Thomas H. Marwick, MBBS, MPH, PH D, a,b Nitesh Nerlekar, MBBS, MPH, PHD
doi : 10.1016/j.jacc.2022.12.021
Volume 81, Issue 9, 7 March 2023, Pages 913-923
Vascular inflammation is a key driver in atherosclerotic progression and plaque rupture. Recent evidence has shown that coronary computed tomography provides a noninvasive method of quantifying coronary inflammation by mapping changes in pericoronary adipose tissue (PCAT) radiodensity, which are associated with cardiovascular diseases.
Maintenance of Competence in Cardiovascular Practice: It’s Time for More Learning, Less Testing
Edward T.A. Fry, MD, FACC, President, American College of Cardiology Jeffrey Kuvin, MD, FACC, Chair,
doi : 10.1016/j.jacc.2023.01.009
Volume 81, Issue 9, 7 March 2023, Pages 924-927
Impact of Vaccination on Major Adverse Cardiovascular Events in Patients With COVID-19 Infection
Joy Jiang, BS Lili Chan, MD, MS Justin Kauffman, BS Jagat Narula, MD, PhD Alexander W. Charney, MD, PhD Wonsuk Oh, PhD Girish Nadkarni, MD, MPH
doi : 10.1016/j.jacc.2022.12.006
Volume 81, Issue 9, 7 March 2023, Pages 928-930
Circulating Vegetable Omega-3 and Prognosis in Patients With Heart Failure: More Data Are Needed
Jiandi Wu, MD Jianqiu Liang, MD, PhD Yuli Huang, MD, PhD
doi : 10.1016/j.jacc.2022.11.062
Volume 81, Issue 9, 7 March 2023, Page e67
Reply: Circulating Vegetable Omega-3 and Prognosis in Patients With Heart Failure: More Data Are Needed
Iolanda Lázaro, PhD Josep Lupón, MD, PhD Germán Cediel, MD, PhD Aleix Sala-Vila, PharmD, PhD *Antoni Bayes-Genis, MD, PhD
doi : 10.1016/j.jacc.2022.12.020
Volume 81, Issue 9, 7 March 2023, Page e69
